ArticleThe Journal of pharmacology and experimental therapeutics2022

Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases.

Surabhi Talele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.